Acella Pharmaceuticals, LLC is a U.S.-based specialty pharmaceutical company dedicated to developing, marketing, and distributing a focused portfolio of prescription and non-prescription healthcare products. They are known for addressing unmet medical needs in therapeutic areas such as endocrinology (e.g., NP Thyroid® for hypothyroidism), women's health, and dermatology. Acella emphasizes quality, affordability, and patient access to essential medications. Acquired by Avion Pharmaceuticals in 2013, it now operates as a key part of Alora Pharmaceuticals, following a strategic merger and rebranding, continuing its mission to improve patient lives through innovative and reliable pharmaceutical solutions.
Serves as the primary corporate office, overseeing commercial operations, product management, marketing, sales support, and administrative functions for Acella's product lines within the Alora Pharmaceuticals framework.
Located in a modern office park in Alpharetta, part of the dynamic Great Oaks office complex, providing contemporary facilities and a professional environment.
The work culture is expected to be professional, patient-focused, and collaborative, reflecting the standards of the pharmaceutical industry. Emphasis is placed on quality, compliance, and achieving results in a dynamic market, integrated with the broader culture of its parent company, Alora Pharmaceuticals.
Alpharetta is part of the greater Atlanta metropolitan area, a growing hub for life sciences, healthcare, and technology companies. This location provides access to a skilled talent pool, industry networks, and robust infrastructure, supporting Acella's operational and strategic objectives.
Acella Pharmaceuticals, LLC primarily focuses its operations and product distribution within the United States market. While its products reach patients nationwide, there is no public information indicating distinct international offices or a direct global operational footprint for Acella itself. International activities, if any, would likely be managed through its parent company, Alora Pharmaceuticals, or via distribution partnerships.
11675 Great Oaks Way, Suite 144
Alpharetta
GA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Acella Pharmaceuticals, LLC' leadership includes:
Acella Pharmaceuticals, LLC has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major executive hires or departures announced specifically for Acella Pharmaceuticals, LLC or its direct parent, Alora Pharmaceuticals, in the last 12 months. The leadership team appears to be stable.
Discover the tools Acella Pharmaceuticals, LLC uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Acella Pharmaceuticals, LLC, as part of Alora Pharmaceuticals, likely uses standardized corporate email formats. The most common format observed for pharmaceutical companies and similar corporations is typically a combination of the employee's first initial and last name.
[first_initial][last]@acellapharma.com
Format
jdoe@acellapharma.com
Example
85%
Success rate
PR Newswire • May 1, 2024
Alora Pharmaceuticals, the parent company of Acella Pharmaceuticals, announced the launch of an authorized generic version of ZYPITAMAG® (pitavastatin) tablets. This move aims to expand affordable treatment options for patients managing high cholesterol....more
PR Newswire • November 29, 2023
Alora Pharmaceuticals, parent of Acella Pharmaceuticals, announced the U.S. launch of a lower-dose 90 mg Nifedipine Extended-Release Tablet, USP. This addition to their cardiology portfolio offers more flexible dosing options for healthcare providers managing hypertension....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Acella Pharmaceuticals, LLC, are just a search away.